Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Review of the pattern of traumatic limb lesions sustained in cases of hanging.

Mc Cabe M, Fyzul NN, Mulligan L, Curtis M, Cassidy M.

J Forensic Leg Med. 2020 Jan;69:101890. doi: 10.1016/j.jflm.2019.101890. Epub 2019 Dec 23.

PMID:
32056808
2.

Metacognitive Therapy for Individuals at High Risk of Developing Psychosis: A Pilot Study.

Parker SK, Mulligan LD, Milner P, Bowe S, Palmier-Claus JE.

Front Psychol. 2020 Jan 17;10:2741. doi: 10.3389/fpsyg.2019.02741. eCollection 2019.

3.

Sexual Harassment in the House of Medicine and Correlations to Burnout: A Cross-Sectional Survey.

Mathews E, Hammarlund R, Kullar R, Mulligan L, Le T, Lauve S, Nzodom C, Crapanzano K.

Ochsner J. 2019 Winter;19(4):329-339. doi: 10.31486/toj.19.0019.

4.

A brief frailty screening tool in Tanzania: external validation and refinement of the B-FIT screen.

Lewis EG, Whitton LA, Collin H, Urasa S, Howorth K, Walker RW, Dotchin C, Mulligan L, Shah B, Mohamed A, Mdegella D, Mkodo J, Zerd F, Gray WK.

Aging Clin Exp Res. 2019 Dec 6. doi: 10.1007/s40520-019-01406-0. [Epub ahead of print]

PMID:
31811571
5.

Acute liver failure in a military recruit treated with valproic acid and harboring a previously unrecognized POLG-1 mutation.

Bassett JT, Rodriguez B, Mulligan L, Fontana RJ.

Epilepsy Behav Rep. 2019 Oct 25;12:100342. doi: 10.1016/j.ebr.2019.100342. eCollection 2019.

6.

GGA3-mediated recycling of the RET receptor tyrosine kinase contributes to cell migration and invasion.

Crupi MJF, Maritan SM, Reyes-Alvarez E, Lian EY, Hyndman BD, Rekab AN, Moodley S, Antonescu CN, Mulligan LM.

Oncogene. 2020 Feb;39(6):1361-1377. doi: 10.1038/s41388-019-1068-z. Epub 2019 Oct 23.

PMID:
31645646
7.

A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis.

Azad T, Nouri K, Janse van Rensburg HJ, Maritan SM, Wu L, Hao Y, Montminy T, Yu J, Khanal P, Mulligan LM, Yang X.

Oncogene. 2020 Jan;39(2):334-355. doi: 10.1038/s41388-019-0988-y. Epub 2019 Sep 2.

PMID:
31477837
8.

GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential.

Mulligan LM.

Front Physiol. 2019 Jan 7;9:1873. doi: 10.3389/fphys.2018.01873. eCollection 2018. Review.

9.

Does exercise improve sleep for adults with insomnia? A systematic review with quality appraisal.

Lowe H, Haddock G, Mulligan LD, Gregg L, Fuzellier-Hart A, Carter LA, Kyle SD.

Clin Psychol Rev. 2019 Mar;68:1-12. doi: 10.1016/j.cpr.2018.11.002. Epub 2018 Nov 16. Review.

PMID:
30617012
10.

Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders.

Hammarlund R, Crapanzano KA, Luce L, Mulligan L, Ward KM.

Subst Abuse Rehabil. 2018 Nov 23;9:115-136. doi: 10.2147/SAR.S183256. eCollection 2018. Review.

11.

Prevalence of Frailty in Older Community-Dwelling Tanzanians According to Comprehensive Geriatric Assessment.

Lewis EG, Wood G, Howorth K, Shah B, Mulligan L, Kissima J, Dotchin C, Gray W, Urasa S, Walker R.

J Am Geriatr Soc. 2018 Aug;66(8):1484-1490. doi: 10.1111/jgs.15433. Epub 2018 Jun 13.

PMID:
29897098
12.

65 YEARS OF THE DOUBLE HELIX: Exploiting insights on the RET receptor for personalized cancer medicine.

Mulligan LM.

Endocr Relat Cancer. 2018 Aug;25(8):T189-T200. doi: 10.1530/ERC-18-0141. Epub 2018 May 9. Review.

PMID:
29743166
13.

The evolving clinical, genetic and therapeutic landscape of multiple endocrine neoplasia type 2.

Moodley S, Weber F, Mulligan LM.

Endocr Relat Cancer. 2018 Feb;25(2):E1-E4. doi: 10.1530/ERC-17-0488. No abstract available.

PMID:
29348305
14.

Spontaneously hypertensive (SHR) rats choose more impulsively than Wistar-Kyoto (WKY) rats on a delay discounting task.

Aparicio CF, Hennigan PJ, Mulligan LJ, Alonso-Alvarez B.

Behav Brain Res. 2019 May 17;364:480-493. doi: 10.1016/j.bbr.2017.09.040. Epub 2017 Sep 27.

PMID:
28963043
15.

Happy 20th anniversary MEN1: from positional cloning to gene function restoration.

Weber F, Mulligan LM.

Endocr Relat Cancer. 2017 Oct;24(10):E7-E11. doi: 10.1530/ERC-17-0346. No abstract available.

PMID:
28899948
16.

Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalization.

Hyndman BD, Crupi MJF, Peng S, Bone LN, Rekab AN, Lian EY, Wagner SM, Antonescu CN, Mulligan LM.

J Cell Sci. 2017 Oct 1;130(19):3282-3296. doi: 10.1242/jcs.203885. Epub 2017 Aug 9.

17.

A comprehensive review on MEN2B.

Castinetti F, Moley J, Mulligan L, Waguespack SG.

Endocr Relat Cancer. 2018 Feb;25(2):T29-T39. doi: 10.1530/ERC-17-0209. Epub 2017 Jul 11. Review.

PMID:
28698189
18.

An Efficient and Flexible Cell Aggregation Method for 3D Spheroid Production.

Maritan SM, Lian EY, Mulligan LM.

J Vis Exp. 2017 Mar 27;(121). doi: 10.3791/55544.

19.

Child with radiologically recurrent thalamic tumor.

Mandiwanza T, Kaliaperumal C, Mulligan L, Ryan E, Looby S, Caird J, Brett F.

Brain Pathol. 2017 Mar;27(2):239-240. doi: 10.1111/bpa.12490. No abstract available.

PMID:
28217956
20.

Differential roles of RET isoforms in medullary and papillary thyroid carcinomas.

Lian EY, Maritan SM, Cockburn JG, Kasaian K, Crupi MJ, Hurlbut D, Jones SJ, Wiseman SM, Mulligan LM.

Endocr Relat Cancer. 2017 Jan;24(1):53-69. Epub 2016 Nov 21.

PMID:
27872141
21.

High resolution examination of the role of sleep disturbance in predicting functioning and psychotic symptoms in schizophrenia: A novel experience sampling study.

Mulligan LD, Haddock G, Emsley R, Neil ST, Kyle SD.

J Abnorm Psychol. 2016 Aug;125(6):788-797. doi: 10.1037/abn0000180. Epub 2016 Jun 30.

PMID:
27362488
22.

Progress and potential impact of RET kinase targeting in cancer.

Mulligan LM.

Expert Rev Proteomics. 2016 Jul;13(7):631-3. doi: 10.1080/14789450.2016.1205491. Epub 2016 Jul 4. No abstract available.

PMID:
27337654
23.

Reduction in membranous immunohistochemical staining for the intracellular domain of epithelial cell adhesion molecule correlates with poor patient outcome in primary colorectal adenocarcinoma.

Wang A, Ramjeesingh R, Chen CH, Hurlbut D, Hammad N, Mulligan LM, Nicol C, Feilotter HE, Davey S.

Curr Oncol. 2016 Jun;23(3):e171-8. doi: 10.3747/co.23.3028. Epub 2016 Jun 9.

24.

From Solo in the Silo to Strategic Training Programs.

Koritzinsky M, Koch CA, Riley B, Beauchemin N, Johnston G, Johnston M, Koropatnick J, Loiselle CG, Maslowska M, McCormick C, Miller WH Jr, Mulligan L, Tsao MS.

CBE Life Sci Educ. 2016 Spring;15(1):le1. No abstract available.

25.

Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.

Smith J, Read ML, Hoffman J, Brown R, Bradshaw B, Campbell C, Cole T, Navas JD, Eatock F, Gundara JS, Lian E, Mcmullan D, Morgan NV, Mulligan L, Morrison PJ, Robledo M, Simpson MA, Smith VE, Stewart S, Trembath RC, Sidhu S, Togneri FS, Wake NC, Wallis Y, Watkinson JC, Maher ER, McCabe CJ, Woodward ER.

Hum Mol Genet. 2016 May 1;25(9):1836-45. doi: 10.1093/hmg/ddw057. Epub 2016 Mar 3.

PMID:
26945007
26.

A systematic review of the nature and correlates of sleep disturbance in early psychosis.

Davies G, Haddock G, Yung AR, Mulligan LD, Kyle SD.

Sleep Med Rev. 2017 Feb;31:25-38. doi: 10.1016/j.smrv.2016.01.001. Epub 2016 Jan 14. Review.

PMID:
26920092
27.

Distinct Temporal Regulation of RET Isoform Internalization: Roles of Clathrin and AP2.

Crupi MJ, Yoganathan P, Bone LN, Lian E, Fetz A, Antonescu CN, Mulligan LM.

Traffic. 2015 Nov;16(11):1155-73. doi: 10.1111/tra.12315. Epub 2015 Sep 21.

28.

Quetiapine immediate release v. placebo for schizophrenia: systematic review, meta-analysis and reappraisal.

Hutton P, Taylor PJ, Mulligan L, Tully S, Moncrieff J.

Br J Psychiatry. 2015 May;206(5):360-70. doi: 10.1192/bjp.bp.114.154377. Review.

PMID:
25934300
29.

Olfactory impairment and traumatic brain injury in blast-injured combat troops: a cohort study.

Xydakis MS, Mulligan LP, Smith AB, Olsen CH, Lyon DM, Belluscio L.

Neurology. 2015 Apr 14;84(15):1559-67. doi: 10.1212/WNL.0000000000001475. Epub 2015 Mar 18.

30.

ATM gene mutations in sporadic breast cancer patients from Brazil.

Mangone FR, Miracca EC, Feilotter HE, Mulligan LM, Nagai MA.

Springerplus. 2015 Jan 15;4:23. doi: 10.1186/s40064-015-0787-z. eCollection 2015.

31.

Cell surface biotinylation of receptor tyrosine kinases to investigate intracellular trafficking.

Crupi MJ, Richardson DS, Mulligan LM.

Methods Mol Biol. 2015;1233:91-102. doi: 10.1007/978-1-4939-1789-1_9.

PMID:
25319892
32.

Recovery-focused cognitive-behavioural therapy for recent-onset bipolar disorder: randomised controlled pilot trial.

Jones SH, Smith G, Mulligan LD, Lobban F, Law H, Dunn G, Welford M, Kelly J, Mulligan J, Morrison AP.

Br J Psychiatry. 2015 Jan;206(1):58-66. doi: 10.1192/bjp.bp.113.141259. Epub 2014 Sep 11. Erratum in: Br J Psychiatry. 2015 Feb;206(2):169.

PMID:
25213157
33.

Genetic features of oligodendrogliomas and presence of seizures. The relationship of seizures and genetics in LGOs.

Mulligan L, Ryan E, O'Brien M, Looby S, Heffernan J, O'Sullivan J, Clarke M, Buckley P, O'Brien D, Farrell M, Brett FM.

Clin Neuropathol. 2014 Jul-Aug;33(4):292-8.

PMID:
24986208
34.

RET revisited: expanding the oncogenic portfolio.

Mulligan LM.

Nat Rev Cancer. 2014 Mar;14(3):173-86. doi: 10.1038/nrc3680. Review.

PMID:
24561444
35.

Negative affect is associated with reporting of both own and others' symptoms.

Mulligan LD, Christie F, Kangura H, Pankhania M, Sambrook S, Samson H, Steadman C, Wang F, Wearden A.

Psychol Health Med. 2014;19(6):738-43. doi: 10.1080/13548506.2013.878803. Epub 2014 Jan 13.

PMID:
24410712
36.

Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.

Bose A, Kandala J, Upadhyay GA, Riedl L, Ahmado I, Padmanabhan R, Gewirtz H, Mulligan LJ, Singh JP.

J Cardiovasc Electrophysiol. 2014 May;25(5):507-513. doi: 10.1111/jce.12348. Epub 2014 Jan 7.

PMID:
24350650
37.

Myofiber prestretch magnitude determines regional systolic function during ectopic activation in the tachycardia-induced failing canine heart.

Howard EJ, Kerckhoffs RC, Vincent KP, Krishnamurthy A, Villongco CT, Mulligan LJ, McCulloch AD, Omens JH.

Am J Physiol Heart Circ Physiol. 2013 Jul 15;305(2):H192-202. doi: 10.1152/ajpheart.00186.2012. Epub 2013 May 10.

38.

Reply: To PMID 23060246.

Xydakis MS, Ling GS, Mulligan LP, Dorlac WC, Hack DC.

Ann Neurol. 2013 Jul;74(1):152-4. doi: 10.1002/ana.23895. Epub 2013 May 14. No abstract available.

PMID:
23526742
39.

The bipolar recovery questionnaire: psychometric properties of a quantitative measure of recovery experiences in bipolar disorder.

Jones S, Mulligan LD, Higginson S, Dunn G, Morrison AP.

J Affect Disord. 2013 May;147(1-3):34-43. doi: 10.1016/j.jad.2012.10.003. Epub 2012 Nov 22.

PMID:
23182591
40.

A randomised controlled trial of recovery focused CBT for individuals with early bipolar disorder.

Jones S, Mulligan LD, Law H, Dunn G, Welford M, Smith G, Morrison AP.

BMC Psychiatry. 2012 Nov 21;12:204. doi: 10.1186/1471-244X-12-204.

41.

Epidemiologic aspects of traumatic brain injury in acute combat casualties at a major military medical center: a cohort study.

Xydakis MS, Ling GS, Mulligan LP, Olsen CH, Dorlac WC.

Ann Neurol. 2012 Nov;72(5):673-81. doi: 10.1002/ana.23757. Epub 2012 Oct 11.

PMID:
23060246
42.

Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy.

Leyva F, Taylor RJ, Foley PW, Umar F, Mulligan LJ, Patel K, Stegemann B, Haddad T, Smith RE, Prasad SK.

J Am Coll Cardiol. 2012 Oct 23;60(17):1659-67. doi: 10.1016/j.jacc.2012.05.054. Epub 2012 Sep 26.

43.

Alternative splicing results in RET isoforms with distinct trafficking properties.

Richardson DS, Rodrigues DM, Hyndman BD, Crupi MJ, Nicolescu AC, Mulligan LM.

Mol Biol Cell. 2012 Oct;23(19):3838-50. doi: 10.1091/mbc.E12-02-0114. Epub 2012 Aug 8.

44.

Multiple functional effects of RET kinase domain sequence variants in Hirschsprung disease.

Hyndman BD, Gujral TS, Krieger JR, Cockburn JG, Mulligan LM.

Hum Mutat. 2013 Jan;34(1):132-42. doi: 10.1002/humu.22170. Epub 2012 Aug 23.

PMID:
22837065
45.

Nursing's future: What's the message?

Johnson JE, Veneziano T, Malast T, Mastro K, Moran A, Mulligan L, Smith AL.

Nurs Manage. 2012 Jul;43(7):36-41. doi: 10.1097/01.NUMA.0000415493.20578.f2. No abstract available.

PMID:
22733053
46.

Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2.

Wagner SM, Zhu S, Nicolescu AC, Mulligan LM.

Clinics (Sao Paulo). 2012;67 Suppl 1:77-84. Review.

47.

Alkyl hydroperoxide reductase: a candidate Helicobacter pylori vaccine.

O'Riordan AA, Morales VA, Mulligan L, Faheem N, Windle HJ, Kelleher DP.

Vaccine. 2012 Jun 6;30(26):3876-84. doi: 10.1016/j.vaccine.2012.04.002. Epub 2012 Apr 15.

PMID:
22512976
48.

Breaking the fall.

Johnson JE, Veneziano T, Green J, Howarth E, Malast T, Mastro K, Moran A, Mulligan L, Smith A.

J Nurs Adm. 2011 Dec;41(12):538-45. doi: 10.1097/NNA.0b013e3182378d53.

PMID:
22094619
49.

Efficient characterization of inhomogeneity in contraction strain pattern.

Nazzal CM, Mulligan LJ, Criscione JC.

Biomech Model Mechanobiol. 2012 May;11(5):585-93. doi: 10.1007/s10237-011-0335-x. Epub 2011 Sep 17.

PMID:
21927825
50.

Supplemental Content

Loading ...
Support Center